Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Dexcom Announces Upcoming Conference Presentations

BusinessWire_EN 
0 0 30.08.23
Dexcom Announces Upcoming Conference Presentations: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
 

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:

  • Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present on behalf of the company at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at 3:45pm (EDT).
  • Sean Christensen, Vice President, Finance and Investor Relations, will present on behalf of the company at the Baird 2023 Global Healthcare Conference on Wednesday, September 13, 2023 at 9:40am (EDT).

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, DexCom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, DexCom works to simplify and improve diabetes management around the world. For more information on DexCom, visit www.dexcom.com.

Category: IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20230830144125/en/

Dexcom Inc. Stock

€62.51
-0.330%
The price for the Dexcom Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.210 (-0.330%).
With 26 Buy predictions and not a single Sell prediction Dexcom Inc. is an absolute favorite of our community.
As a result the target price of 121 € shows a very positive potential of 93.57% compared to the current price of 62.51 € for Dexcom Inc..
Show more
Like: 0
Share
BusinessWire_EN 
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments

Not a member yet? Sign up for free!